|
|||||
|
|
Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis |
|
| Authors: | Michael Li MD Jordan S Sack MD MPH Osama E Rahma MD F Stephen Hodi MD Stephen D Zucker MD Shilpa Grover MD MPH |
| Institution: | 1. Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts;2. Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts
Harvard Medical School, Boston, Massachusetts;3. Harvard Medical School, Boston, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts |
| Abstract: | |
| Keywords: | hepatitis immune checkpoint inhibitor immunotherapy melanoma |